Clicky

I-Mab(IMAB)

Description: I-Mab is a clinical stage biopharmaceutical company. It engages in discovering, developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zhang Zang on June 30, 2016 and is headquartered in Pudong, China.


Keywords: Biotechnology Cancer Biopharmaceutical Life Sciences Disease Medication Pharmacy Autoimmune Disorders Immune Disorders

Home Page: www.i-mabbiopharma.com

IMAB Technical Analysis

New Bund Center
Shanghai, 200124
China
Phone: 86 21 6057 8000


Officers

Name Title
Dr. Jingwu Zhang Zang M.D., Ph.D. Founder & Chairman
Dr. Andrew X. Zhu M.D., Ph.D. Member of Scientific Advisory Board, Pres, Acting CEO & Director
Dr. Jerry Wang Co-Founder & Chief Scientific Officer
Mr. Richard L. Yeh M.B.A. Interim CFO, COO & Director
Mr. Tianyi Zhang VP of Investor Relations
Mr. Cheng Li Chief Legal Officer
Ms. Gigi Qi Feng Chief Communications Officer
Dr. Weiming Tang Ph.D. Exec. VP of Global Bus. Devel. & Chief Bus. Officer
Dr. Fernando J. SalleĀ“s Ph.D. Sr. VP and Head of U.S. & EU Bus. Devel.
Mr. Ivan Yifei Zhu Chief Commercial Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.5874
Price-to-Sales TTM: 2.5452
IPO Date: 2020-01-17
Fiscal Year End: December
Full Time Employees: 378
Back to stocks